Cytoplasmic mRNA decay controlling inflammatory gene expression is determined by pre-mRNA fate decision
Molecular Cell · 2025-02 · 85 (4) · 742-755.e9
DOI: 10.1016/j.molcel.2025.01.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025-02. Verfasst von Annika Bestehorn und 15 weiteren Autor:innen. Beteiligte Einrichtung: Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030 Vienna, Austria; University of Vienna, Max Perutz Labs, Department of Microbio…. Hauptthemen laut MEDLINE: Tristetraprolin, RNA Stability, RNA Precursors, Inflammation. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund.
Abstract (Originalsprache)
The fidelity of immune responses depends on timely controlled and selective mRNA degradation that is largely driven by RNA-binding proteins (RBPs). It remains unclear whether stochastic or directed processes govern the selection of an individual mRNA molecule for degradation. Using human and mouse cells, we show that tristetraprolin (TTP, also known as ZFP36), an essential anti-inflammatory RBP, destabilizes target mRNAs via a hierarchical molecular assembly. The assembly formation strictly relies on the interaction of TTP with RNA. The TTP homolog ZFP36L1 exhibits similar requirements, indicating a broader relevance of this regulatory program. Unexpectedly, the assembly of the cytoplasmic mRNA-destabilization complex is licensed in the nucleus by TTP binding to pre-mRNA, which we identify as the principal TTP target rather than mRNA. Hence, the fate of an inflammation-induced mRNA is decided concomitantly with its synthesis. This mechanism prevents the translation of excessive and potentially harmful inflammation mediators, irrespective of transcription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr.-Bohr-Gasse 9, 1030 Vienna, Austria; University of Vienna, Max Perutz Labs, Department of Microbiology, Immunobiology and Genetics, Dr.-Bohr-Gasse 9, 1030 Vienna, Austr…
- Mass Spectrometry Facility, Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr. Bohr-Gasse 7, 1030 Vienna, Austria.
- University of Natural Resources and Life Sciences, Vienna, Department of Chemistry, Institute of Biochemistry, Muthgasse 18, 1190 Vienna, Austria.
- Mass Spectrometry Facility, Max Perutz Labs, Vienna Biocenter Campus (VBC), Dr. Bohr-Gasse 7, 1030 Vienna, Austria; University of Vienna, Max Perutz Labs, Department for Biochemistry and Cell Biology, Vienna Biocenter C…
Förderung
- Austrian Science Fund
Zitieren
APA
Bestehorn, A., von Wirén, J., Zeiler, C., Fesselet, J., Didusch, S., Forte, M., Doppelmayer, K., Borroni, M., Le Heron, A., Scinicariello, S., Chen, W., Baccarini, M., Pfanzagl, V., Versteeg, G. A., Hartl, M., & Kovarik, P. (2025). Cytoplasmic mRNA decay controlling inflammatory gene expression is determined by pre-mRNA fate decision. Molecular Cell, 85(4), 742-755.e9. https://doi.org/10.1016/j.molcel.2025.01.001
Vancouver
Bestehorn A, von Wirén J, Zeiler C, Fesselet J, Didusch S, Forte M, et al. Cytoplasmic mRNA decay controlling inflammatory gene expression is determined by pre-mRNA fate decision. Molecular Cell. 2025;85(4):742-755.e9. doi:10.1016/j.molcel.2025.01.001
BibTeX
@article{Bestehorn2025,
author = {Bestehorn, Annika and von Wirén, Julius and Zeiler, Christina and Fesselet, Jeanne and Didusch, Sebastian and Forte, Maurizio and Doppelmayer, Kevin and Borroni, Martina and Le Heron, Anita and Scinicariello, Sara and Chen, WeiQiang and Baccarini, Manuela and Pfanzagl, Vera and Versteeg, Gijs A and Hartl, Markus and Kovarik, Pavel},
title = {Cytoplasmic mRNA decay controlling inflammatory gene expression is determined by pre-mRNA fate decision},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {4},
pages = {742--755.e9},
doi = {10.1016/j.molcel.2025.01.001}
}
EUVIMED